Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Stefanie Castellanos at s.castellanos@oxfordglobal.co.uk 

2018 Drug Discovery Summit and Discovery Chemistry & Drug Design Congress Confirmed Speakers Include:

Magnus Walter, Chief Scientific Officer Global Neurodegeneration
Eli Lilly

Petr Vachal, Vice President Discovery Chemistry
MSD

Philip Tagari, Vice President Research
Amgen

Anna Maroney, Vice President, Head of Alliance Management
AbbVie

Thorsten Thormann, Senior Vice President New Product Discovery
LEO Pharma

Juergen Gamer, Vice President Business Development
Apogenix

Yolanda Chong, Vice President Biology
Recursion Pharmaceuticals

Nils Jakob Vest Hansen, Chief Executive Officer
Vipergen ApS

Alexander Alanine, Chief Operating Officer
Bactevo

Vivek K Vishnudas, Chief Technology Officer
Berg

Thomas Franch, Chief Scientific Officer
Nuevolution

Dmitry Samarsky, Chief Scientific Officer
Silence Therapeutics

Mark Throsby, Chief Scientific Officer
Merus BV

Christel Menet, Chief Scientific Officer
Confo Therapeutics

Hubert Haag, Director Lead Discovery – Global Sourcing & External Business Opportunities
Sanofi

Jag Heer, Director of Medicinal Chemistry
UCB

Mike Hann, GSK Senior Fellow & Director, Drug Design & Selection
GlaxoSmithKline

Rob Howes, Director Reagents and Assay Development, Discovery Sciences
AstraZeneca

Ray Kemper, Director Discovery and Investigative Toxicology
Vertex

Joel Klappenbach, Director, Applied Genomics
MSD

Malin Lemurell, Director of Medicinal Chemistry
AstraZeneca

Jing Li, Director of Pharmacology, Screening and Triage
MSD

Carl Petersson, Scientific Director Drug Disposition
Merck KGaA

Wei-Sheng Huang, Director of Discovery Chemistry
Takeda

Daniel Zwilling, Director of CNS Discovery
Circuit Therapeutics

Julie Selkirk, Associate Director Biology
Celgene

Georgios Stamatas, Research Associate Director
Johnson & Johnson

Nathan Brown, Head Cheminformatics
BenevolentAI

Jose Duca, Head, Computer-Aided Drug Discovery
Novartis

Christoph Dumelin, Laboratory Head
Novartis

Florian Fuchs, CBT Screening Sciences, Head Cellular Assays
Novartis

Tobias Gabriel, Head External Drug Discovery
Novartis

Anish Konkar, Cluster Head, GI Endocrinology & Obesity
Sanofi-Aventis

Amaury Fernández Montalván, Laboratory Head
Bayer

Gerhard Hessler, Head of Synthetic Molecular Design
Sanofi

Joerg Knaeblein, Head of CoLaborator, Berlin & Technology Scouting
Bayer

Ulrich Schopfer, Head Integrated Target and Lead Discovery
Novartis

Franz Schuler, Head Drug Disposition and Safety, Pharmaceutical Sciences
Roche

Alan Whitmore, Head of Discovery Biology
e-Therapeutics

Lutz Mueller, Distinguished Scientist
F. Hoffmann-La Roche

Phil Cox, Senior Principal Research Scientist, FBDD Chemistry Group Leader
AbbVie

Ye Che, Senior Principal Scientist
Pfizer

Hasane Ratni, Senior Principal Scientist
F. Hoffmann-La Roche

Jörg Bentzien, Principal Scientist
FORMA Therapeutics

Bart DeCorte, Principal Scientist
Johnson & Johnson

Peter Ellmark, Principal Scientist
Alligator Bioscience

Stefan Geschwinder, Principal Scientist
AstraZeneca

Mike Morrison, Principal Scientist
Epizyme

Jonathan Wingfield, Principal Scientist
AstraZeneca

Dan Blat, Senior Scientist Preclinical Biology
Immunocore Ltd.

Iulia Diaconu, Senior Scientist I
Bluebird Bio

Anthony Donofrio, Senior Scientist HTE and Lead Discovery Capabilities
MSD

Vineet Pande, Senior Scientist Molecular Informatics
Janssen

Davide Gianni, Team Leader Discovery Biology
AstraZeneca

Steve Andrews, Head of Chemistry
Cambridge Drug Discovery Institute

Paul Andrews, Director of Operations, National Phenotypic Screening Centre
University of Dundee

Rod Hubbard, Senior Fellow and Professor
Vernalis and University of York

Ernesto Freire, Henry Walters Professor
Johns Hopkins University

Jonathan Hall, Professor
ETH Zurich

Magnus Ingelman-Sundberg, Professor
Karolinska Institutet

Johannes Kirchmair, Professor of Applied Bioinformatics
University of Hamburg

Richard Meehan, Professor
Edinburgh University

Kristian Strømgaard, Professor, Director
University of Copenhagen

Paul Brennan, Associate Professor, Medicinal Chemistry
University of Oxford

Olivia Rossanese, Head of Biology and Reader
The Institute of Cancer Research

Fredrik Wermeling, Assistant Professor
Karolinska Institutet

Co-located 2018 Microbiome Discovery & Development Congress Confirmed Speakers Include:

Patrice Garnier, Chief Executive Officer
AMAbiotics

Veronika Oudova, Chief Executive Officer
S-Biomedic

Catherine O’Neill, Chief Executive Officer
SkinBio Therapeutics

Nikole Kimes, Founder and Vice President
Siolta Therapeutics

Lionel Breton, Global Director of Open Research
L’Oreal

Imke Mulder, Research Director
4D Pharma

Alexander Sulakvelidze, Executive Vice-President and Chief Scientific Officer
Intralytix

Colette Shortt, Regulatory Director, Global Franchise Organisation
J&J Consumer

Ross O. Youngs, Founder and CEO
Biosortia Pharmaceuticals

Sandrine Claus, Chief Scientific Officer
LNC Therapeutics